Omecat (Omeprazole)

Omeprazole, the active ingredient in Omecat, is a Proton Pump Inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to manage conditions such as gastro‑reflux disease and ulcers in adults.

GNH USA supplies Omecat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition. - Erosive esophagitis: aids the healing of erosive damage to the esophageal lining. - NSAID‑induced ulcer prophylaxis: helps prevent ulcer formation in patients regularly using non‑steroidal anti‑inflammatory drugs. - H‑